Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Retained Earnings (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Retained Earnings for 14 consecutive years, with -$254.4 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 2.52% to -$254.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$254.4 million through Dec 2025, down 2.52% year-over-year, with the annual reading at -$254.4 million for FY2025, 2.52% down from the prior year.
  • Retained Earnings hit -$254.4 million in Q4 2025 for STRATA Skin Sciences, roughly flat from -$254.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$220.3 million in Q2 2021 to a low of -$254.5 million in Q3 2025.
  • Historically, Retained Earnings has averaged -$235.6 million across 5 years, with a median of -$233.7 million in 2023.
  • Biggest five-year swings in Retained Earnings: dropped 1.05% in 2021 and later fell 4.94% in 2024.
  • Year by year, Retained Earnings stood at -$221.7 million in 2021, then decreased by 2.5% to -$227.2 million in 2022, then dropped by 4.77% to -$238.1 million in 2023, then dropped by 4.24% to -$248.1 million in 2024, then decreased by 2.52% to -$254.4 million in 2025.
  • Business Quant data shows Retained Earnings for SSKN at -$254.4 million in Q4 2025, -$254.5 million in Q3 2025, and -$252.8 million in Q2 2025.